Efficacy of a third SARS-CoV-2 mRNA vaccine dose among hematopoietic cell transplantation, CAR T cell, and BiTE recipients

Cancer Cell. 2022 Apr 11;40(4):340-342. doi: 10.1016/j.ccell.2022.02.010. Epub 2022 Feb 23.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19 Vaccines
  • COVID-19* / prevention & control
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • SARS-CoV-2 / genetics
  • T-Lymphocytes
  • Vaccines, Synthetic
  • mRNA Vaccines

Substances

  • COVID-19 Vaccines
  • Vaccines, Synthetic
  • mRNA Vaccines